Medical Schools Nurses Pharmacokinetics 
The Pharma Data
SEPTEMBER 7, 2021
The first patients have been enrolled in a phase 1 randomized placebo-controlled clinical trial to study a therapeutic vaccine for opioid use disorder developed by researchers at the University of Minnesota Medical School.
The Pharma Data
DECEMBER 3, 2020
Safety and Pharmacokinetics of Antisense Oligonucleotide STK-001 in Children and Adolescents with Dravet Syndrome: Single and Multiple Ascending Dose Design for the Open-Label Phase 1/2a MONARCH Study. The primary endpoints are safety, tolerability and pharmacokinetic (PK) profile of STK-001 in Dravet syndrome patients.
Expert insights. Personalized for you.
52 
Let's personalize your content